Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Doctors have warned of some hidden and potentially fatal side effects of using Ozempic amid the increasing popularity of the ...

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...